← FDA Drug Approvals (Drugs@FDA)
KALLIGA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2017-05-17
Drug application
- FDA Application #
ANDA207081
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- KALLIGA
- Generic name
- DESOGESTREL AND ETHINYL ESTRADIOL
- Active ingredients
- DESOGESTREL; ETHINYL ESTRADIOL
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- Afaxys Pharma, LLC
- First approval
- 2017-05-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown